Bharat Biotech International Ltd
Show jobs for this employer
21 articles with Bharat Biotech International Ltd
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for February 16, 2021.
-
Clinical Catch-Up: December 14-18
12/21/2020
Many companies appear to be getting their clinical trial news updated ahead of the holidays. Here’s a look. -
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 1, 2020.
-
Bharat Biotech, Thomas Jefferson University pursue a promising vaccine candidate against COVID-19
5/20/2020
The vector used in this new COVID-19 vaccine under accelerated development program is a deactivated rabies vaccine that is known to produce a strong immune response, and is approved for the whole population including children and pregnant women.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 20, 2020.
-
Bharat Biotech Says Working On Two Possible Zika Vaccines
2/3/2016
-
Bharat Biotech Vaccine Doses Touch 1 Billion
2/4/2010
-
Bharat Biotech Begins Phase I Clinical Trials of HN-VAC - its Cell Culture H1N1 Vaccine
1/22/2010
-
Bharat Biotech's Rabies Vaccine ‘INDIRAB(R)’ Sales Crosses 10 Million Doses; Sales Expected to Double in Coming Years as Demand Increases in Developing World
10/28/2009
-
Bharat Biotech Inks Pact with Orissa Govt to set up Rs 100 cr ‘Konark Knowledge Park’
10/27/2009
-
Bharat Biotech's Anti-Staphylococcal Molecule 'Lysostaphin' Secures Patent Rights; Could Become Drug of Choice for Treating Life Threatening S.aureus Bacteremia
9/30/2009
-
Bharat Biotech Launches COMVAC5(R) the First Indigenously Developed Single Shot Pentavalent Combination Vaccine
3/2/2009
-
Bharat Biotech REVAC-B+(TM) – Hepatitis B Vaccine Crosses 150 million Mark
10/30/2008
-
Bharat Biotech Wins Orissa Government’s First PPP “Biotech Pharma IT Park” Project
10/29/2008
-
Bharat Biotech Announces Successful Completion Of Its Phase I/II Clinical Trial For 116E Rotavirus Vaccine
5/27/2008
-
ThromboGenics Ltd. Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
9/4/2007
-
Bharat Biotech Launches Two New Vaccines
9/4/2007
-
ThromboGenics Ltd. Announces License Agreement With Bharat Biotech For Novel Thrombolytic Agent
12/6/2006
-
Novavax, Inc. And Bharat Biotech To Develop Flu Vaccine
3/6/2006
-
Acambis PLC - RE Agreement
11/8/2005